Literature DB >> 24860631

What's new in renal cell cancer research? Highlights of GU-ASCO 2014.

Anil Kapoor1.   

Abstract

One of the major areas of research presented at the 2014 Genitourinary Cancers Symposium (GU-ASCO 2014) pertained to the management of renal cell cancer (RCC). The following pages provide a summary of some of the most important presentations and posters presented during the 3-day symposium.

Entities:  

Year:  2014        PMID： 24860631      PMCID： PMC4001680          DOI： 10.5489/cuaj.2014

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


  2 in total

1.  Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Authors:  Daniel Y C Heng; J Connor Wells; Brian I Rini; Benoit Beuselinck; Jae-Lyun Lee; Jennifer J Knox; Georg A Bjarnason; Sumanta Kumar Pal; Christian K Kollmannsberger; Takeshi Yuasa; Sandy Srinivas; Frede Donskov; Aristotelis Bamias; Lori A Wood; D Scott Ernst; Neeraj Agarwal; Ulka N Vaishampayan; Sun Young Rha; Jenny J Kim; Toni K Choueiri
Journal:  Eur Urol       Date:  2014-06-13       Impact factor: 20.096

2.  Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.

Authors:  A Ari Hakimi; Irina Ostrovnaya; Anders Jacobsen; Katalin Susztak; Jonathan A Coleman; Paul Russo; Andrew G Winer; Roy Mano; Alexander I Sankin; Robert J Motzer; Martin H Voss; Kenneth Offit; Mark Purdue; Mark Pomerantz; Matthew Freedman; Toni K Choueiri; James J Hsieh; Robert J Klein
Journal:  Cancer       Date:  2015-10-27       Impact factor: 6.860
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.